Enterprise News > industry news

Big Movement in Precision Medicine Industry in 2016

2016-07-08

In February, 2016, researchers from IOWA University successfully made precision medicine strategy for an oculopathy patient by the way of Individualized proteomics, which made a major achievement in PM treatment.

On March 8th, precision medicine treatment was listed as one of the first priority projects which will be implemented during the year, according to "Notice about publishing national important research plans and precision medicine research project applying guide in the year of 2016 by Ministry of Science and Technology".

On April 15th, about 30 experts from biological medicine, information, big-data and clinical medicine background and officers from Chinese Academy of Sciences, Health Department of General Logistics and National Natural Science Foundation of China, etc. were invited by National Health and Family Planning Commission and Ministry of Science and Technology, to discuss the implementing principles, targets and key points about precision medicine for the development of strategy of the country.

In May, the Australian Premier announced the Zero Kid Cancer Project, aiming at providing incurable kid cancer patients with individual treatment strategy using the genome technology.

On 25th, June, Chinese government published "Notice about the project arrangement publicity of national important research plan: precision medicine research", put the project in audition list onto public. 61 projects were in the list and the expenditure support was RMB 640 million.

In the beginning of July, Obama announced that 55 million USD will be invested to set up the precision medicine public database, which will cover more than 1 million volunteers' detailed health information. The database will be used in the research of diseases and personalized medicine and treatment.

On 8th, July, "Nature Reviews Cancer" published summary uncovering the current development of biomarker in precision medicine. Taking lung cancer as an example, 4 promising biomarkers were discussed. The summary also analyzed the challenges of national precision medicine research.

Industry News

Big Movement in Precision Medicine Industry in 2016

2016-07-08

In February, 2016, researchers from IOWA University successfully made precision medicine strategy for an oculopathy patient by the way of Individualized proteomics, which made a major achievement in PM treatment.

On March 8th, precision medicine treatment was listed as one of the first priority projects which will be implemented during the year, according to "Notice about publishing national important research plans and precision medicine research project applying guide in the year of 2016 by Ministry of Science and Technology".

On April 15th, about 30 experts from biological medicine, information, big-data and clinical medicine background and officers from Chinese Academy of Sciences, Health Department of General Logistics and National Natural Science Foundation of China, etc. were invited by National Health and Family Planning Commission and Ministry of Science and Technology, to discuss the implementing principles, targets and key points about precision medicine for the development of strategy of the country.

In May, the Australian Premier announced the Zero Kid Cancer Project, aiming at providing incurable kid cancer patients with individual treatment strategy using the genome technology.

On 25th, June, Chinese government published "Notice about the project arrangement publicity of national important research plan: precision medicine research", put the project in audition list onto public. 61 projects were in the list and the expenditure support was RMB 640 million.

In the beginning of July, Obama announced that 55 million USD will be invested to set up the precision medicine public database, which will cover more than 1 million volunteers' detailed health information. The database will be used in the research of diseases and personalized medicine and treatment.

On 8th, July, "Nature Reviews Cancer" published summary uncovering the current development of biomarker in precision medicine. Taking lung cancer as an example, 4 promising biomarkers were discussed. The summary also analyzed the challenges of national precision medicine research.